Beta Bionics, Inc. Common Stock

€10.07
EUR
Last updated on --.
24h volume696.19K
24h highest10.5006 EUR
24h lowest9.7531 EUR
24h Price movement-0.85%

BBNX recent prices

24 Hours
-0.85%-€0.08593
30 days
+10.05%+€0.91945
60 days
+10.04%+€0.92804
90 days
-9.98%-€1.118

Key data

Previous close10.1569 EUR
Market cap387.13M EUR
Volume696.19K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.2804 EUR
Net income (FY)-57.09M EUR
Revenue (FY)94.73M EUR
Last report date21 Apr 2026

About Beta Bionics, Inc. Common Stock

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
HeadquartersIRVINE
Employees (FY)423.00
Revenue per employee (FY)223.94K EUR
Net income per employee (FY)-134.97K EUR
Listed onNasdaq
Official website

BBNX conversion tables

BBNXBBNX
EUREUR
0.5 BBNX5.035 EUR
1 BBNX10.07 EUR
5 BBNX50.35 EUR
10 BBNX100.7 EUR
EUREUR
BBNXBBNX
0.5 EUR0.049648 BBNX
1 EUR0.099295 BBNX
5 EUR0.49648 BBNX
10 EUR0.99295 BBNX

FAQ

BBNX is trading at €10.07, -0.85% over the last 24 hours. Track live moves on the price chart at the top of this page.
The BBNX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. BBNX is currently trading at €10.07, -0.85% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on BBNX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. BBNX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from BBNX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against BBNX's historical range and other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.
Beta Bionics, Inc. Common Stock's market cap is currently 387.13M EUR. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume696.19K
24h highest10.5006 EUR
24h lowest9.7531 EUR
24h Price movement-0.85%
BBNXBBNX
EUREUR
Start trade with BBNX Perpetual